Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded
- Contract number
- SPE2DB25FU9GV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,362
Award facts
- Contract value 100% obligated
- $1,362.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,362.35 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Monovisc 88 mg/4 mL syringes. This non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid-based viscosupplement used for knee osteoarthritis treatment, indicating this delivery supports medical supply needs within the federal healthcare system, particularly for military and veteran care.
This delivery order operates under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen has demonstrated capability to fulfill federal procurement requirements through competitive awards and maintains ongoing relationships with the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FU9GV?
SPE2DB25FU9GV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FU9GV worth?
The government has obligated $1,362 on SPE2DB25FU9GV.
Is contract SPE2DB25FU9GV an order under another contract?
Yes. SPE2DB25FU9GV is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FU9GV competed?
The extent of competition for SPE2DB25FU9GV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award